Apyx Medical (APYX) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.67% |
| Dec 31, 2025 | -5.41% |
| Sep 30, 2025 | -10.41% |
| Jun 30, 2025 | -8.69% |
| Mar 31, 2025 | -9.61% |
| Dec 31, 2024 | -11.60% |
| Sep 30, 2024 | -14.77% |
| Jun 30, 2024 | -13.47% |
| Mar 31, 2024 | 2.84% |
| Dec 31, 2023 | 21.34% |
| Sep 30, 2023 | -11.48% |
| Jun 30, 2023 | 18.60% |
| Mar 31, 2023 | 13.31% |
| Dec 31, 2022 | 0.48% |
| Sep 30, 2022 | 9.53% |
| Jun 30, 2022 | 14.28% |
| Mar 31, 2022 | 17.92% |
| Dec 31, 2021 | 15.17% |
| Sep 30, 2021 | 27.06% |
| Jun 30, 2021 | 30.04% |
| Mar 31, 2021 | 33.13% |
| Dec 31, 2020 | 27.09% |
| Sep 30, 2020 | 26.95% |
| Jun 30, 2020 | 26.79% |
| Mar 31, 2020 | 27.26% |
| Dec 31, 2019 | 59.30% |
| Sep 30, 2019 | 58.96% |
| Jun 30, 2019 | 64.60% |
| Mar 31, 2019 | 37.01% |
| Dec 31, 2018 | 15.93% |
| Sep 30, 2018 | 74.67% |
| Mar 31, 2018 | 18.26% |
| Dec 31, 2017 | 19.04% |
| Sep 30, 2017 | 15.96% |
| Jun 30, 2017 | 15.61% |
| Mar 31, 2017 | 22.81% |
| Dec 31, 2016 | 25.57% |
| Sep 30, 2016 | 11.52% |
| Jun 30, 2016 | 10.29% |
| Mar 31, 2016 | 16.25% |
| Dec 31, 2015 | 27.00% |